Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

LABORATORIO REIG JOFRE (FEQ1) Stock Price & Analysis

FEQ1 Stock Chart & Stats

€2.53€0.02(0.80%)
At close: 1:00 AM GMT+1
€2.6€2.65€2.78 May19 May10 Jul
Day’s Range
EUR 2.51 - EUR 2.53
52-Week Range
EUR 2.13 - EUR 2.91
Previous Close
EUR 2.51
Volume
N/A
Average Volume (3M)
0
Market Cap
EUR 212.43M
Enterprise Value
EUR 329.17M
Total Cash (Recent Filing)
EUR 14.78M
Total Debt (Recent Filing)
EUR 119.58M
Price to Earnings (P/E)
30.8
Beta
0.34
Next Earnings
Nov 13, 2026 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
0.75%

Bulls Say, Bears Say

Bulls Say

Business Model Diversification

A dual revenue model (branded/specialty medicines plus CDMO services) provides structural balance: product sales drive margin upside while contract manufacturing supplies recurring fee-based revenue and capacity utilization, reducing single-source demand risk and supporting steady cash flow over cycles.

Moderate Leverage And Equity Growth

Historically moderate debt levels and gradual equity growth create a resilient capital structure. This affords the company room to fund working capital and targeted investments without excessive refinancing risk, supporting durable operational continuity and strategic optionality over the medium term.

Pre-2025 Revenue And Margin Stability

A multi-year track record of revenue growth and ~10–11% EBITDA margins through 2024 indicates underlying product demand and operational scalability. That historical stability implies the business model can re-assert profitable growth if 2025-specific headwinds are addressed and volumes/pricing recover.

Bears Say

Sharp 2025 Revenue & Margin Hit

A large year-on-year revenue decline and collapse in operating margins materially undermine sustainable earnings power. Such deterioration reduces retained earnings available for reinvestment and makes achieving prior returns difficult without clear signs of demand recovery or cost restructuring.

Weak And Volatile Cash Generation

A swing to deeply negative free cash flow and uneven operating cash undermines self-funded investment and increases reliance on external financing. Persistent cash volatility raises execution risk for capex, R&D, and capacity commitments, constraining durable growth and strategic flexibility.

Lower ROE And Rising Leverage In 2025

Declining ROE coupled with higher leverage reduces capital efficiency and shareholder return potential. This combination increases sensitivity to further profit shocks, limits ability to pursue M&A or expansion without additional financing, and raises the long-term cost of capital.

LABORATORIO REIG JOFRE News

FEQ1 FAQ

What was LABORATORIO REIG JOFRE’s price range in the past 12 months?
LABORATORIO REIG JOFRE lowest stock price was €2.13 and its highest was €2.91 in the past 12 months.
What is LABORATORIO REIG JOFRE’s market cap?
LABORATORIO REIG JOFRE’s market cap is €212.43M.
When is LABORATORIO REIG JOFRE’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were LABORATORIO REIG JOFRE’s earnings last quarter?
LABORATORIO REIG JOFRE released its earnings results on Jul 31, 2026. The company reported €0.005 earnings per share for the quarter.
Is LABORATORIO REIG JOFRE overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does LABORATORIO REIG JOFRE pay dividends?
LABORATORIO REIG JOFRE does not currently pay dividends.
What is LABORATORIO REIG JOFRE’s EPS estimate?
LABORATORIO REIG JOFRE’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does LABORATORIO REIG JOFRE have?
LABORATORIO REIG JOFRE has 82,883,400 shares outstanding.
What happened to LABORATORIO REIG JOFRE’s price movement after its last earnings report?
LABORATORIO REIG JOFRE reported an EPS of €0.005 in its last earnings report. Following the earnings report the stock price went down -1.141%.
Which hedge fund is a major shareholder of LABORATORIO REIG JOFRE?
Currently, no hedge funds are holding shares in DE:FEQ1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology